Spots Global Cancer Trial Database for Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
Official Title: A Phase II Study of Hypofractionated Image Guided Proton Therapy for Low and Intermediate Risk Prostate Cancer
Study ID: NCT02040610
Conditions
Interventions
Study Description
Brief Summary: This study is being proposed to evaluate the use of moderate hypofractionated proton therapy in low and intermediate risk prostate cancer patients. Quality of life outcomes as well as gastrointestinal and genitourinary early and late toxicities will be analyzed and compared to conventional proton therapy regimens. It is thought that this regimen will produce comparable findings and would result in substantial health care cost savings, as well as, be more convenient for patients.
Detailed Description: Patients will receive: 62 Gy (RBE) in 20 fractions of 3.1 Gy (RBE) over 4 weeks
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Provision Cares Proton Therapy Center Knoxville, Knoxville, Tennessee, United States
Provision Cares Proton Therapy Center Nashville, Nashville, Tennessee, United States
Contact Details
Name: J. Ben Wilkinson, M.D.
Affiliation: Provision Center for Proton Therapy
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
